Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Deere A Case Study in Compounded Returns

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Airplane interior
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Deere has been a standout performer in the market over the past five years, with an impressive average annual return of 17.44%. If you had invested $100 in DE stock five years ago, it would now be worth $217.50, based on the current price of $360.50. Deere’s Return on Capital Employed (ROCE) is an impressive 21%, surpassing the industry average of 12%. In the last five years, Deere has seen a substantial increase in returns on capital, reaching 21% with a 40% rise in capital employed. Over the past decade leading up to February 28, 2024, Deere has delivered a total return of 425.77%.

The key lesson to learn from Deere’s performance is the power of compounded returns in growing cash over time. By consistently reinvesting capital at higher rates of return, Deere has proven its ability to effectively compound returns, making it an appealing choice for many investors.

DE Stock Performance Update: February 28, 2024 – Minor Decline with Potential for Recovery

On February 28, 2024, DE (Deere & Company) experienced a slight decrease in its stock performance. DE closed at $360.66, marking a $2.55 drop from the previous market close, representing a 0.70% decrease. Despite this decline, there was a small uptick in after-hours trading, with the stock rising by $0.13. Investors and analysts will be closely monitoring DE’s performance in the coming days to see if it can regain its footing and potentially reverse the recent downward trend. It is essential for DE to demonstrate resilience and adaptability in order to navigate the challenges ahead. Stock performance can be influenced by a wide range of variables, and staying informed is key to making sound financial choices.

DE Stock Performance Analysis: Revenue and Net Income Increase in Past Year, Decrease in First Quarter

On February 28, 2024, DE stock performance was closely scrutinized by investors and analysts after the company released its financial data for the past year and the first quarter of the current year. DE reported a total revenue of $61.22 billion for the past year, which represented a 16.59% increase compared to the previous year. However, total revenue for the first quarter of the current year was reported at $12.19 billion, showing a significant decrease of 20.92% compared to the previous quarter.

DE also reported a net income of $10.17 billion for the past year, reflecting a 42.56% increase compared to the previous year. However, net income for the first quarter of the current year was reported at $1.75 billion, showing a decrease of 26.09% compared to the previous quarter.

Earnings per share (EPS) for DE were reported at $34.63 for the past year, representing a 48.73% increase compared to the previous year. However, EPS for the first quarter of the current year was reported at $6.23, showing a decrease of 24.55% compared to the previous quarter.

The fluctuation in DE’s financial performance between the past year and the first quarter of the current year may have raised concerns among investors. It will be important for DE to address any underlying issues that may have contributed to the decrease in financial performance in the first quarter and demonstrate a clear strategy for future growth and success.

Tags: DE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare cloud based

Mizuho Analyst Upgrades Fidelity National Information Services FIS with 76 Price Target

Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Scilex Holding Company Partners with National Pharmacy Chains to Distribute GLOPERBA Expanding Access to Effective Gout Flare Prophylaxis

Luxury vacation

Polestar Automotive Quarterly Earnings Preview

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com